Rokote Laboratories at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Rokote Laboratories takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth SU24. Rokote Laboratories offers vaccines given through the nose and carried by an adenovirus vector, with COVID-19 as its first target.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Rokote Laboratories
Helsinki, Finland
rokote.com
BiotechStart-up Plus
Develops intranasal adenovirus-vector vaccines, led by a nasal COVID-19 vaccine in early clinical trials.
Booth
Exhibiting at Booth SU24
Talk
Tue Oct 20
13:10
Start-up Pitch 7: FINVAC: A Clinically Validated Intranasal Vaccine Platform for Infectious Diseases
Startup Pitches
Platforms & deliveryInfectious disease & AMR

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Rokote Laboratories

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction